Literature DB >> 3086114

Schistosoma mansoni: chemotherapy of infections of different ages.

A A Sabah, C Fletcher, G Webbe, M J Doenhoff.   

Abstract

Mice were treated with potassium antimony tartrate, hycanthone, oxamniquine, niridazole, or praziquantel at different times after infection with Schistosoma mansoni. The rate of cure was assessed by perfusion of surviving worms approximately 4 weeks after treatment, and the percentage reduction in worm burden was estimated relative to the number of adult worms perfused from control mice, comparably infected but untreated. All six drugs were relatively inactive against S. mansoni between 3 and 4 weeks after infection when compared with treatment at 5 to 6 weeks. However, the drugs differed in the patterns of cure they achieved in the 2-week period after administration of cercariae and in the period around the onset of patency. Worms that had been subjected to amoscanate or hycanthone in the third week after infection showed evidence of this as adults in having a reduced fecundity. Factors such as worm or host physiology, or host immune status may have had roles in the outcome of chemotherapy at different stages of maturation of S. mansoni.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086114     DOI: 10.1016/0014-4894(86)90184-0

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  112 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

3.  Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

4.  Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose.

Authors:  Shu-Hua Xiao; Chao-Wei Zhang
Journal:  Parasitol Res       Date:  2010-06-08       Impact factor: 2.289

Review 5.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

6.  Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine.

Authors:  Shu-hua Xiao; Jian Xue; Binggui Shen
Journal:  Parasitol Res       Date:  2010-02-20       Impact factor: 2.289

7.  Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

Authors:  Hong-jun Li; Wei Wang; Guo-li Qu; You-zi Li; Yong-hui Tao; Yun-tian Xing; Xiao-ting Wang; Yang Dai; Jian-ying Wei; Jian-rong Dai; Gerald C Coles; You-sheng Liang
Journal:  Parasitol Res       Date:  2011-10-18       Impact factor: 2.289

8.  Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration.

Authors:  Shu-Hua Xiao; Jun Sun; Jian Xue; Xi-Ling Du; Hao-Bing Zhang
Journal:  Parasitol Res       Date:  2011-07-13       Impact factor: 2.289

9.  Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.

Authors:  Lalit Kumar Sharma; Pauline M Cupit; Tino Goronga; Thomas R Webb; Charles Cunningham
Journal:  Bioorg Med Chem Lett       Date:  2014-04-13       Impact factor: 2.823

10.  Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.

Authors:  Stephanie Howe; Dorina Zöphel; Harini Subbaraman; Clemens Unger; Jana Held; Thomas Engleitner; Wolfgang H Hoffmann; Andrea Kreidenweiss
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.